Data reveals a possible increase in risk of treatable blood disorder from AstraZeneca Vaccine
New analysis from Scotland has found there may be a possible, though small, increased risk of developing a condition called idiopathic thrombocytopenic purpura (ITP) after administration of the Oxford/AstraZeneca Vaccine.
Doctors assure patients that the condition is treatable and often mild and it is more often seen in those who have pre-existing health conditions such as diabetes, heart disease or kidney disease.
The condition has also been seen in patients after taking other vaccines including the flu, MMR and hepatitis B.
Source: The Guardian, 9 June 2021